Tandem Diabetes Care Inc (NASDAQ:TNDM), a medical device company and manufacturer of the t:slim Insulin Pump, announced that Kim Blickenstaff, president and CEO, will present a company update at the following upcoming investor conferences: Deutsche Bank 39th Annual Health Care Conference, which will be held on Thursday, May 8, 2014. Bank of America Merrill Lynch 2014 Health Care Conference, which will be held on Wednesday, May 14, 2014. Tandem Diabetes Care Inc (NASDAQ:TNDM), shares after opening at $15.10 moved to $16.07 on last trade day and at the end of the day closed at $15.31. Company price to sales ratio in past twelve months was calculated as 12.13 and price to cash ratio as 2.72. Tandem Diabetes Care Inc (NASDAQ:TNDM), showed a negative weekly performance of 12.86%.
On May 06, 2014, Conatus Pharmaceuticals Inc (NASDAQ:CNAT), announced that it will report financial results for the first quarter ended March 31, 2014, after the market close on Tuesday, May 13, 2014. Conatus Pharmaceuticals Inc (NASDAQ:CNAT), shares fell 3.09% in last trading session and ended the day on $5.64. Conatus Pharmaceuticals Inc (NASDAQ:CNAT), return on equity ratio is recorded as 505.30% and its return on assets is -15.00%.
ArQule, Inc. (NASDAQ:ARQL), reported Q1 EPS of ($0.11), in-line with the analyst estimate of ($0.11). At March 31, 2014, the Company had a total of $85,758,000 in cash, equivalents and marketable securities. ArQule, Inc. (NASDAQ:ARQL), shares moved down 1.99% in last trading session and was closed at $1.48, while trading in range of $ 1.45 – 1.55. ArQule, Inc. (NASDAQ:ARQL), year to date (YTD) performance is -31.16%.
On May 05, 2014, Hanger Inc (NYSE:HGR), announced net sales of $235.6 million for the quarter ended March 31, 2014, an increase of $6.2 million from net sales of $229.4 million for the first quarter of 2013. Hanger Inc (NYSE:HGR), weekly performance is -11.91%. On last trading day company shares ended up $30.54. Hanger Inc (NYSE:HGR), distance from 50-day simple moving average (SMA50) is -11.35%. Analysts mean target Price for the company is $39.20.
Leave a Reply